CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan ALX Oncology Holdings Inc. - ALXO CFD

4.63
4.14%
0.05
Rendah: 4.56
Tinggi: 4.84
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.83
Open* 4.78
1-Year Change* -74.08%
Day's Range* 4.56 - 4.84
52 wk Range 4.52-19.85
Average Volume (10 days) 447.44K
Average Volume (3 months) 4.79M
Market Cap 198.48M
P/E Ratio -100.00K
Shares Outstanding 40.86M
Revenue N/A
EPS -3.03
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date May 8, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 24, 2023 4.63 -0.13 -2.73% 4.76 4.84 4.54
Mar 23, 2023 4.83 0.29 6.39% 4.54 4.87 4.54
Mar 22, 2023 4.78 -0.04 -0.83% 4.82 4.95 4.63
Mar 21, 2023 4.79 0.09 1.91% 4.70 5.02 4.68
Mar 20, 2023 4.60 -0.16 -3.36% 4.76 4.78 4.49
Mar 17, 2023 4.76 -0.15 -3.05% 4.91 4.95 4.63
Mar 16, 2023 4.98 -0.08 -1.58% 5.06 5.13 4.92
Mar 15, 2023 5.17 0.09 1.77% 5.08 5.38 4.67
Mar 14, 2023 5.23 -0.49 -8.57% 5.72 5.74 5.07
Mar 13, 2023 5.60 0.42 8.11% 5.18 5.90 5.18
Mar 10, 2023 5.36 -0.33 -5.80% 5.69 5.73 5.02
Mar 9, 2023 5.84 -0.27 -4.42% 6.11 6.19 5.60
Mar 8, 2023 6.21 -0.16 -2.51% 6.37 6.39 6.11
Mar 7, 2023 6.37 0.07 1.11% 6.30 6.54 6.29
Mar 6, 2023 6.44 -0.04 -0.62% 6.48 6.48 6.20
Mar 3, 2023 6.50 0.19 3.01% 6.31 6.67 6.31
Mar 2, 2023 6.45 0.11 1.74% 6.34 6.47 6.23
Mar 1, 2023 6.48 0.04 0.62% 6.44 6.60 6.43
Feb 28, 2023 6.59 0.16 2.49% 6.43 6.66 6.43
Feb 27, 2023 6.63 0.15 2.31% 6.48 6.74 6.48

ALX Oncology Holdings Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018
Total revenue 0 1.182 4.796 2.067
Revenue 0 1.182 4.796 2.067
Cost of Revenue, Total 1.075 4.36 1.88
Gross Profit 0.107 0.436 0.187
Total Operating Expense 83.555 45.466 23.979 15.751
Selling/General/Admin. Expenses, Total 23.385 14.809 3.313 2.601
Research & Development 60.17 28.961 16.306 11.27
Operating Income -83.555 -44.284 -19.183 -13.684
Interest Income (Expense), Net Non-Operating -0.013 -0.811 -0.021 0
Other, Net 0.084 -0.404 -0.005 -0.002
Net Income Before Taxes -83.484 -45.499 -19.209 -13.686
Net Income After Taxes -83.463 -45.74 -19.243 -13.731
Net Income Before Extra. Items -83.463 -45.74 -19.243 -13.731
Net Income -83.463 -45.74 -19.243 -13.731
Total Adjustments to Net Income 0 -5.202 -4.028 -3.671
Income Available to Common Excl. Extra. Items -83.463 -50.942 -23.271 -17.402
Income Available to Common Incl. Extra. Items -83.463 -50.942 -23.271 -17.402
Diluted Net Income -83.463 -50.942 -23.271 -17.402
Diluted Weighted Average Shares 40.308 18.4853 34.7116 34.7116
Diluted EPS Excluding Extraordinary Items -2.07063 -2.7558 -0.67041 -0.50133
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -2.07063 -2.73397 -0.67041 -0.50133
Unusual Expense (Income) 0 0.621
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 0 0 0 0 0
Revenue 0 0 0 0
Total Operating Expense 24.747 28.472 24.576 16.299 14.208
Selling/General/Admin. Expenses, Total 7.674 7.578 6.362 5.086 4.359
Research & Development 17.073 20.894 18.214 11.213 9.849
Operating Income -24.747 -28.472 -24.576 -16.299 -14.208
Interest Income (Expense), Net Non-Operating 0.225 -0.003 -0.004 -0.003 -0.003
Other, Net -0.011 0.016 0.014 0.028 0.026
Net Income Before Taxes -24.533 -28.459 -24.566 -16.274 -14.185
Net Income After Taxes -24.533 -28.438 -24.566 -16.274 -14.185
Net Income Before Extra. Items -24.533 -28.438 -24.566 -16.274 -14.185
Net Income -24.533 -28.438 -24.566 -16.274 -14.185
Total Adjustments to Net Income 0 0 0 0
Income Available to Common Excl. Extra. Items -24.533 -28.438 -24.566 -16.274 -14.185
Income Available to Common Incl. Extra. Items -24.533 -28.438 -24.566 -16.274 -14.185
Diluted Net Income -24.533 -28.438 -24.566 -16.274 -14.185
Diluted Weighted Average Shares 40.6163 40.5297 40.3962 40.2471 40.0554
Diluted EPS Excluding Extraordinary Items -0.60402 -0.70166 -0.60813 -0.40435 -0.35413
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.60402 -0.70166 -0.60813 -0.40435 -0.35413
Cost of Revenue, Total 0 0
Gross Profit 0 0
Unusual Expense (Income) 0
  • Annual
  • Quarterly
2021 2020 2019 2018
Total Current Assets 367.019 435.992 9.809 10.208
Cash and Short Term Investments 363.667 434.219 9.017 8.262
Cash 434.219 9.017 8.262
Total Receivables, Net 0 0.536 0.932
Accounts Receivable - Trade, Net 0 0.536 0.932
Prepaid Expenses 3.352 1.773 0.256 1.014
Total Assets 380.183 436.054 10.676 11.164
Property/Plant/Equipment, Total - Net 3.397 0.052 0.86 0.956
Property/Plant/Equipment, Total - Gross 3.46 0.077 2.309 1.976
Accumulated Depreciation, Total -0.063 -0.025 -1.449 -1.02
Other Long Term Assets, Total 9.767 0.01 0.007 0
Total Current Liabilities 15.295 6.204 4.984 1.873
Accounts Payable 3.764 0.004 3.748 0.697
Accrued Expenses 11.102 6.049 1.046 0.905
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 0.151 0.19 0.271
Total Liabilities 17.134 6.209 10.952 2.009
Total Long Term Debt 0.28 0 5.421 0
Long Term Debt 5.421 0
Other Liabilities, Total 1.559 0.005 0.547 0.136
Total Equity 363.049 429.845 -0.276 9.155
Preferred Stock - Non Redeemable, Net 70.363 60.933
Common Stock 0.041 0.04 0.021 0.021
Additional Paid-In Capital 564.993 548.327 2.122 1.74
Retained Earnings (Accumulated Deficit) -201.985 -118.522 -72.782 -53.539
Total Liabilities & Shareholders’ Equity 380.183 436.054 10.676 11.164
Total Common Shares Outstanding 40.5871 39.8445 34.7116 34.7116
Redeemable Preferred Stock 0
Cash & Equivalents 363.667
Current Port. of LT Debt/Capital Leases 0.429
Capital Lease Obligations 0.28
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 321.525 367.019 388.963 412.277 432.327
Cash and Short Term Investments 316.596 363.667 385.149 409.964 429.855
Cash & Equivalents 159.086 363.667 385.149 409.964 429.855
Prepaid Expenses 4.929 3.352 3.814 2.313 2.472
Total Assets 363.676 380.183 399.728 421.289 432.91
Property/Plant/Equipment, Total - Net 6.967 3.397 3.362 0.167 0.047
Property/Plant/Equipment, Total - Gross 7.088 3.46 3.401 0.2 0.077
Accumulated Depreciation, Total -0.121 -0.063 -0.039 -0.033 -0.03
Other Long Term Assets, Total 10.075 9.767 7.403 8.845 0.536
Total Current Liabilities 15.308 15.295 12.488 13.979 14.129
Accounts Payable 5.133 3.764 3.683 5.806 7.35
Accrued Expenses 9.746 11.102 8.376 7.744 2.735
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.429 0.429 0.429 0.429 0.095
Other Current Liabilities, Total 3.949
Total Liabilities 20.08 17.134 14.556 16.275 14.426
Total Long Term Debt 0.175 0.28 0.385 0.489 0.131
Capital Lease Obligations 0.175 0.28 0.385 0.489 0.131
Other Liabilities, Total 4.597 1.559 1.683 1.807 0.166
Total Equity 343.596 363.049 385.172 405.014 418.484
Redeemable Preferred Stock 0
Common Stock 0.041 0.041 0.04 0.04 0.04
Additional Paid-In Capital 570.679 564.993 558.679 553.955 551.151
Retained Earnings (Accumulated Deficit) -226.518 -201.985 -173.547 -148.981 -132.707
Total Liabilities & Shareholders’ Equity 363.676 380.183 399.728 421.289 432.91
Total Common Shares Outstanding 40.6566 40.5871 40.4863 40.3253 40.2086
Short Term Investments 157.51
Long Term Investments 25.109
Other Equity, Total -0.606
  • Annual
  • Quarterly
2021 2020 2019 2018
Net income/Starting Line -83.463 -45.74 -19.243 -13.731
Cash From Operating Activities -68.101 -38.289 -14.249 -13.19
Cash From Operating Activities 0.051 0.202 0.429 0.431
Non-Cash Items 19.338 7.002 0.308 0.269
Changes in Working Capital -4.027 0.247 4.257 -0.159
Cash From Investing Activities -4.923 0.61 -0.353 -0.653
Capital Expenditures -4.923 -0.031 -0.353 -0.653
Cash From Financing Activities 2.472 462.881 15.357 0.001
Issuance (Retirement) of Stock, Net 2.753 473.235 9.44 0.001
Issuance (Retirement) of Debt, Net -0.281 0 5.917 0
Net Change in Cash -70.552 425.202 0.755 -13.842
Cash Taxes Paid 0.274 0.047
Cash Interest Paid 0.011 0.427
Other Investing Cash Flow Items, Total 0.641
Financing Cash Flow Items -10.354
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -24.533 -83.463 -55.025 -30.459 -14.185
Cash From Operating Activities -20.674 -68.101 -50.613 -25.757 -5.135
Cash From Operating Activities 0.058 0.051 0.017 0.011 0.005
Non-Cash Items 5.926 19.338 8.688 4.241 1.858
Cash Interest Paid 0 0.011 0.007 0.003 0
Changes in Working Capital -2.125 -4.027 -4.293 0.45 7.187
Cash From Investing Activities -183.921 -4.923 -0.405 -0.007 -0.007
Capital Expenditures -0.589 -4.923 -0.405 -0.007 -0.007
Cash From Financing Activities 0.08 2.472 1.948 1.509 0.778
Issuance (Retirement) of Stock, Net 0.185 2.753 2.125 1.582 0.778
Net Change in Cash -204.515 -70.552 -49.07 -24.255 -4.364
Cash Taxes Paid 0 0.274 0.274 0.274
Financing Cash Flow Items 0 0
Issuance (Retirement) of Debt, Net -0.105 -0.281 -0.177 -0.073
Other Investing Cash Flow Items, Total -183.332 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
VenBio Partners LLC Private Equity 23.8003 9699925 0 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 14.9987 6112789 1482504 2022-12-31 LOW
Lightstone Ventures, L.P. Investment Advisor 11.1076 4526963 -194027 2022-03-31 LOW
Vivo Capital, LLC Venture Capital 10.3546 4220048 0 2022-12-31 MED
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 7.0445 2871000 0 2022-12-31 LOW
Logos Global Management LLC Investment Advisor 5.7651 2349600 -621752 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.7051 1510050 40991 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.4941 1424043 14289 2022-12-31 LOW
Eventide Asset Management, LLC Investment Advisor 2.2132 902000 0 2022-12-31 MED
Cormorant Asset Management, LP Hedge Fund 1.5018 612079 -100000 2022-12-31 MED
Redmile Group, LLC Investment Advisor/Hedge Fund 1.4905 607470 -144627 2022-12-31 LOW
Pons (Jaume) Individual Investor 1.3244 539746 -3232 2022-12-29 LOW
Invus Public Equities Advisors, LLC Investment Advisor 1.2268 500000 0 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.171 477236 90049 2022-12-31 MED
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 1.1386 464029 -685 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.0117 412309 18988 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.9656 393550 8987 2022-12-31 LOW
DWS Investments UK Limited Investment Advisor 0.84 342355 142 2022-12-31 MED
Pier Capital, LLC Investment Advisor 0.667 271848 -769 2022-12-31 MED
Randolph (Sophia) Individual Investor 0.6631 270253 44857 2022-12-29 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Bio Therapeutic Drugs

323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
Biaya inap posisi Long -0.0194%
Biaya inap posisi short -0.0025%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

BTC/USD

27,724.20 Price
+0.420% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 66.00

XRP/USD

0.46 Price
+9.350% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00357

US100

12,798.80 Price
+0.420% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 3.0

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda